GSK and Amgen to add medicines to TrumpRx, Fox Business reports
13/03/2026 23:36
March 13 (Reuters) - GSK GSK.L and Amgen AMGN.O will add their medicines to TrumpRX, the prescription drug website launched by President Donald Trump's administration, Fox Business reported on Friday. (Reporting by Ismail Shakil and Costas Pitas; Editing by Chris Reese) ((Costas.Pitas@thomsonreuters.com; Reuters Messaging: @Cpitas on X))
Recent news on Amgen
See all newsFactbox: Global drugmakers invest billions to boost US presence
China's Harbour BioMed to focus on another patent case after $20 million damages award
Amgen owes $20.2 million in antibody patent lawsuit, US jury says (updated)
Amgen owes $20.2 mln in antibody patent lawsuit, US jury says
Amgen taps research firm to reassess Tavneos data (updated)